Search bioRxiv⌕ Search

bioRxiv · 10.1101/2025.02.17.638675

NRGRank: Coarse-grained structurally-informed ultra-massive virtual screening

Abstract

NRGRank is a coarse-grained structurally-informed virtual screening Python package with accuracy comparable to docking-based methodologies but up to 100-fold speed increase. NRGRank is based on a coarse-grained evaluation of pairwise atom-type pseudo-energy interactions that implicitly accounts for compound and side-chain flexibility as well as limited backbone movements. We compare NRGRank to docking-based virtual screening software Glide, Autodock Vina and DOCK 3.7 on the DUD-E virtual screening benchmark using enrichment factors at 1% (EF1). We observe broad variations of EF1 values across targets, structural models and methods. For apo form or AlphaFold2 models, out of a subset of 37 targets from DUD-E, NRGRank has better EF1 values than Glide for 12 and 13 targets respectively. Even in holo form, where the accuracy of classical docking software increases, NRGRank has better EF1 values than 13, 10 and 5 targets out of 37 compared to AutoDock Vina, DOCK 3.7 and Glide respectively. Comparing the rank of true binders in Glide and NRGRank shows that true binders ranked in the top 1% are complementary between methods irrespective of the target form (AlphaFold, apo or holo). That is, utilizing NRGRank detects binders that are missed by Glide (and presumably other methods), whereas those found by Glide are missed by NRGRank. Furthermore, we observe that most hits found by NRGRank within the top 50 predictions (4.38 {+/-} 5.49 hits on average for AF2 targets) remain once the top 1% of predictions are re-scored with Glide, but the hit rate within the top 50 predictions increases. NRGRank can evaluate one molecule in 0.3 s on average, enabling a modern laptop with 8 cores to screen 1,000,000 molecules in 24 hours - up to two orders of magnitude faster than the reported speed of DOCK 3.7, AutoDock Vina running on GPUs and Glide. NRGRank occupies a unique niche among tools for virtual screening being insensitive to structural inaccuracies but with comparable accuracy as state-of-the-art docking methods and fast as AI-based methods but without the dangers of overfitting as it is based on 780 pseudo-energy parameters. Combined with the fact that NRGRank does not require extensive or expensive computational resources or expert pre-processing of targets, it is unique in making high-performance ultra-massive virtual screening accessible to all.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

DesCoteaux, T., Najmanovich, R.. 2025-02-21. NRGRank: Coarse-grained structurally-informed ultra-massive virtual screening. https://doi.org/10.1101/2025.02.17.638675

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Design of colipids with controlled lateral distance of head group moieties for targeting strategies in the field of lipid-based nanoparticles

Lipid nanoparticles and liposomes are nanoparticle drug formulations which are firmly established in clinics. In order to expand their application and improve efficacy, surface modifications can be a key strategy, especially for cell specific targeting. Targeting can be achieved by integrating ligand functionalized lipids or lipidoids on the nanoparticle surface. In this case, not solely the targeting ligand itself, but also the structure of the whole targeting lipid/lipidoid can affect the interaction of the targeting ligand with the binding motive on cells. Especially, distal spacer structures between lipid anchor and ligand unit, often composed of polyethylene glycol chains, provide a certain distance of the ligand from the nanoparticle surface. A concept which is currently neglected is the control of the lateral distance between ligand structures on the nanoparticle. Herein we investigated the possibility to design lipidoids with a lateral spacer composed of polyethylene glycol units. We synthesized and characterized different lipidoids which provide a primary amine in the head group for possible ligand coupling. In our model lipidoids the head groups were functionalized with a paramagnetic probe to apply electron paramagnetic resonance (EPR) methods for the characterization of the lipidoid interaction with model nanoparticles, in our case liposomes. Continuous wave EPR was used to study the efficiency of the novel lipidoids to integrate into lipid bilayers of model liposomes, which was shown to depend on lipidoid structure and liposome composition. Furthermore, using double electron-electron resonance (DEER), we observed lipidoid conformational changes occurring upon integration into liposomes.

biophysics↗

Binding mechanisms of therapeutic antibodies to human claudin-18.2

Claudin-18.2 (CLDN18.2) is a tight junction component with highly restricted expression in the paracellular space of nonmalignant gastric epithelial cells. It becomes accessible on tumor cell surface during malignant transformation, making CLDN18.2 an attractive target for targeted therapies against gastric cancer. Recently, zolbetuximab has become the first FDA-approved monoclonal antibody that targets CLDN18.2 in advanced gastric cancer, and others like osemitamab have entered phase 3 clinical trials. However, the high-resolution structure of CLDN18.2 is lacking, and how CLDN18.2 is recognized by therapeutic antibodies remains undefined. Here, we report cryo-EM structures of human claudin-18.2 (hCLDN18.2) in complex with the Fab fragments of zolbetuximab and osemitamab, revealing the structure of hCLDN18.2 and its binding mechanism to the therapeutic antibodies. Further analyses reveal that three residues in the first extracellular loop of hCLDN18.2 that are different from human claudin-18.1 (hCLDN18.1) play a critical role in antibody binding. Our data elucidate the structural basis for selective binding of therapeutic antibodies to hCLDN18.2, which should aid rational design of next-generation immunotherapies targeting hCLDN18.2.

biophysics↗

Structural relationships between the SLC12 cotransporter C-terminal domain, universal stress proteins and adenylating enzymes

Several SLC12 cotransporters bind ATP in a cytoplasmic C-terminal domain (CTD). We analysed 16,192 CTD-containing SLC12 sequences and compared 42,845 representative structures to examine the relationship between this nucleotide site, universal stress proteins (USPs) and adenylating enzymes. In phosphorylated NKCC1, D891 and D927 lie near the ATP phosphate chain, while R801 and K889 form a basic phosphate-binding clamp. NKCC1 retains this arrangement, whereas KCC paralogs replace or lose several corresponding groups. In structural comparisons with USP and adenylating-enzyme references, both CTD lobes score between universal stress proteins and EC-annotated domains, and the two lobes form separate lineages that include bacterial transporters. Lobe-specific and nucleotide-frame comparisons place ATP in the corresponding structural region used for -phosphate chemistry by catalytic members of this fold. Published work on UspG provides a precedent for protein-bound AMP in a natural USP. In the examined SLC12 structures and USP models, candidate protein hydroxyls lack an in-line geometry for attack at ATP P. Protein adenylation would require a change in protein or nucleotide geometry, or a different acceptor. These results define a structural basis for testing conditional protein adenylation at SLC12 nucleotide sites. The required evidence is a covalent protein-AMP adduct, identification of its acceptor and measurement of the expected pyrophosphate coproduct, with soluble nucleotide analysis to distinguish accompanying ATP reactions.

biophysics↗